2021 IPO

Pear Therapeutics Stock

Digital Therapeutics Platform

Sign up today and learn more about Pear Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2013

Notable Investors

Trustbridge Partners

Headquarters

Boston MA, US

Total Funding

$274M

About Pear Therapeutics Stock

Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to help treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia. 

Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts. Notable investors include Softbank Vision Fund, Temasek Holdings, and Perceptive Advisors.

Investors

QUAD Investment Management

Pear Therapeutics

Bridge Builders Collaborative

Pear Therapeutics

Forth Management

Pear Therapeutics

Funding History

February 2016$18.7M
December 2017$51.0M
December 2018$64.4M
December 2020$32.0M
December 2020$107M

Management

Chief Executive Officer

Corey McCann

Chief Financial Officer

Chris Guiffre

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo